An independent comparison, read through an endo lens

For seven years, they told youit was your weight.


You counted the appointments. You kept the pain diary no one read. You were handed a diet sheet and sent home to try harder. Havelle begins somewhere else — by believing you — and then looks, carefully, at which providers offer metabolic care as though the rest of you exists.

A note we make first, and keep everywhere: metabolic and weight care is one pillar of whole-woman care that sits alongside endometriosis-specific treatment. GLP-1 medications, including compounded tirzepatide, are not a treatment for endometriosis.

Find who fits → Read the Charter

Havelle is an independent editorial comparison of telehealth providers who prescribe compounded GLP-1 medication. We read thirteen of them against one question women with endometriosis rarely get to ask out loud: will this provider treat me as a whole person, or as a number on a chart? No provider pays to appear here or to rank, we list them alphabetically, and the rating never moves for money.

The Whole-Woman Charter

Seven promises — written for a body that has been dismissed before

Before you compare anyone, it helps to know what “good” should feel like. These are the seven promises we hold every provider against, each with why it matters when you live with endo.

1

Sees the whole you

Reads your full history — pain and hormones included — and never reduces you to a number on a chart.

2

Believed, not dismissed

Care built to listen, without the “just lose weight” brush-off you have already heard.

3

Metabolic support, honestly framed

Takes weight, insulin and inflammation seriously as one part of your plan, and never pretends it treats endometriosis.

4

A dose made for your body

503A compounded titration matched to how you respond, not a one-size ladder.

5

A human who answers

Real help, quickly, when something goes wrong.

6

Care that lasts

Maintenance and a medically guided step-down, so results hold.

7

Honest, upfront cost

Pricing you can read before you commit.

Read the Whole-Woman Charter in full →

The Whole-Care Match

Three questions, and the providers that actually fit

We weight the seven promises by what has worn you down and what would help most, then filter by budget. Nothing here is pay-to-play — the same honest scores drive every result.

Take the Whole-Care Match →

The comparison

All thirteen, in alphabetical order

The petals show how each provider scored across the seven promises; the bloom sums them into a Whole-Care Rating. Price sits in its own column — it never moves a provider up or down.

Open the full comparison →

Reading room

Nine things worth understanding before you choose

Your questions

GLP-1 options for endometriosis: what they do and what they don’t

No GLP-1 is approved to treat endometriosis, and none should be offered to you as one. What they can be, what to ask an intake nurse, and how all thirteen providers score.

Read the answer →
Be heard

The appointment script: how to be heard in a weight-care visit

What to say in the first five minutes, what a good clinician asks next, and the phrases that tell you to keep looking.

Read the guide →
The wait

Seven years to a diagnosis: why endo care takes so long

The average endometriosis diagnosis takes seven to ten years. Here is what happens across those years — and why the delay was never a measure of your effort.

Read the guide →
The honest line

The metabolic side of endo — one pillar, not a cure

Weight, insulin and inflammation deserve honest attention. But GLP-1 medications, including compounded tirzepatide, do not treat endometriosis, its lesions or its pain — this is about caring for the whole body around the disease, never the disease itself.

Read the guide →
The first visit

How to tell, in one visit, whether a provider will actually listen

Five questions to ask — and three answers to listen for — that reveal whether you are being seen or simply sorted.

Read the guide →
Your questions

Wegovy and endometriosis: what the early research shows

What a 2026 patient survey reported, why a survey cannot show cause, and why no GLP-1 is a treatment for endometriosis.

Read the answer →
Know your baseline

Side effect or endo flare? How to tell the difference

A two-week baseline to write down before your first dose, what to track after, and when to call someone.

Read the guide →
Two prescriptions

On endo hormone therapy? The conversation to have first

What the tirzepatide label says about oral hormonal medication, and what to ask each of your clinicians.

Read the guide →
Check them first

Is this GLP-1 provider legit? A ten-minute check

Five things a trustworthy program puts in writing, including what it says about endometriosis.

Read the guide →
Before surgery

Endo surgery while on a GLP-1: what your team needs to know

Why anesthesia teams ask, what changed in the 2024 guidance, and the five details to put in your pre-op paperwork.

Read the guide →
Honest cost

Endo care and a GLP-1 on one budget

How to read a GLP-1 price honestly when endometriosis care already has a line in your budget.

Read the guide →

Trust & method

How the ratings are built, and what they will never claim

A rating you can read at a glance, a formula that does not move for money, and one line we hold everywhere: GLP-1 medications are not a treatment for endometriosis.

Read the method in full →